420 with CNW — Marijuana Advocates See Rescheduling as Tool to Enact Reforms in Prohibitionist States

The anticipated reclassification of cannabis by the federal government to a less-dangerous category may not have an immediate effect on states where cannabis use for either recreational or medical purposes is still illegal. Nonetheless, cannabis legalization proponents see the federal shift as potentially influencing state policymakers who have been hesitant about endorsing cannabis.

Matthew Schweich, head of the Marijuana Policy Project, a prolegalization advocacy group, often encounters state legislators who express potential support but are reluctant due to federal illegality. While reclassification wouldn’t legalize cannabis outright, Schweich believes it could alleviate some concerns among state legislators, potentially making them more inclined to support legalization efforts.

The U.S. Drug Enforcement Administration’s proposal aims to move marijuana from Schedule I to III of the Controlled Substances Act. This shift would entail less-stringent regulation, though the process may not conclude until after the upcoming presidential election. In the interim, the proposed change could provide new arguments for proponents of ballot initiatives seeking cannabis legalization. Florida is set to vote on a constitutional change for recreational marijuana in November 2024. Similar votes are anticipated in South Dakota and Nebraska, where efforts are underway to legalize recreational cannabis and permit private companies to cultivate and distribute it.

Moreover, former police officer Mark Friese, now a criminal defense lawyer in North Dakota, is in favor of a program to legalize cannabis in the state. In his opinion, those efforts may greatly benefit from the federal reclassification.

However, not everyone is convinced of the impact of reclassification. Jackee Winters, leading a group in Idaho advocating for medical cannabis legalization, finds it challenging to gather support due to fear of legal repercussions.

The potential federal change may have a limited effect in states where marijuana is already legal for recreational or medical use. Still, advocates hope it could sway opinions in states with more restrictive laws or outright bans on cannabis.

In Georgia, although low-THC marijuana products have been allowed since 2015 for specific medical conditions, purchasing them legally only became possible last year. A federal reclassification could ease restrictions, allowing pharmacists to handle cannabis products much as they do any other prescription medication.

Meanwhile, in states such as Tennessee where elected officials are hesitant to support marijuana legislation, a federal reclassification could spark conversations. However, some, such as Senate Speaker Randy McNally, remain cautious, noting that many issues would persist even if marijuana were downgraded to Schedule III.

Kansas faced a similar scenario where attempts to legalize medical cannabis met strong opposition, particularly from law enforcement officials concerned about potential ramifications.

In Texas, limited access to low-THC marijuana products is allowed by law, but efforts to expand access have faced criticism. Similarly, in Wyoming, past efforts to decriminalize cannabis or legalize medical use have not gained traction.

Despite these challenges, there’s optimism among advocates that federal reclassification could ease resistance and encourage more legislators to seriously consider legalization. Apollo Pazell, who has been involved in previous legalization efforts, believes that resistance will diminish over time.

Existing cannabis companies such as SNDL Inc. (NASDAQ: SNDL) will probably wait for the reclassification process to be completed so that they can assess how they can realign their strategic direction in light of the evolving landscape at the federal level.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Vape South America Medellín 2024 to Showcase Innovation in Alternative Products Supply Chain

Alternative Products Expo has announced the return of the world’s premier counterculture industry event to Medellín, Colombia. Another first-class production of ZJ EventsVape South America Medellín 2024 is slated to take place at the Centro de Convenciones Plaza Mayor in Medellín from May 18-19, 2024. Strategically located with a welcoming atmosphere and great climate, the Vape South America Medellín 2024 has become a prime gateway between the U.S. and South American markets and offers a unique opportunity to establish connections with buyers and distributors from around the globe. “Vape South America Medellín 2024 is a globally renowned platform in the counterculture industry, uniquely positioned to facilitate cross-geographical partnerships,” said Sebastian Carmona, director of partnerships at ZJ Events. “Medellín’s dynamic environment provides the perfect backdrop to showcase innovative products and drive collaboration in the alternative products supply chain.”

To view the full press release, visit https://cnw.fm/Lhxaj

About Vape South America

Vape South America Medellín 2024 is the place to connect with top manufacturers, explore the latest trends and innovations, and take advantage of exclusive show discounts in a fun and exciting atmosphere at the world’s largest counterculture and vape trade show. This is a revolutionary business-networking festival attracting top manufacturers, buyers, suppliers, and industry professionals. Visit VAPE SOUTH AMERICA – MEDELLÍN 2024 to secure tickets for the event and view details to become an exhibitor or sponsor the expo.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks — Green Label Summit 2023 to Showcase Insights and Innovations Shaping the Future of Cannabis

The highly-anticipated Green Label Summit 2023, hosted by Jotia Group, is set to shine in the shimmering lights of Las Vegas on Sept. 13 – 14 at The Expo, World Market Center. The event is designed to deliver an unparalleled platform for dynamic discussions and visionary insights into the ever-evolving cannabis industry. The summit will feature the Psychedelic Horizons Forum, captivating sessions and masterclasses, with a special emphasis on the future of cannabis. Throughout the event, experts will share invaluable market predictions and insights into medical advancements, product development, evolving regulations, consumer choices, tourism, cultivation and growing green, and cutting-edge innovations in marketing technologies that are shaping the future of the industry. “There has never been a greater need for an inclusive event than this. In order to move forward for the greater good of all, we must work together,” Founder and Director John Richard said of the event. “The reconciliation between consumption, consumerism and medical needs, spiritual growth and cultural respect in conjunction with compliance and business growth- I see a great vision for this industry, and I am honored to speak with and be part of this community.”

To view the full press release, visit https://cnw.fm/xYYk1

About Green Label Summit 2023

Hosted by Jotia Group, the Green Label Summit 2023 will feature renowned speakers, masterclasses, panel sessions and forums that highlight the dynamic cannabis industry and insights into its future. Topics will include unlocking financial success, advancements in medical cannabis and psychedelics, cannabis criminal justice reform and reentry, fostering inclusion, innovative technology, the art and science of cannabis cultivation, and more. Throughout the event, participants will have the unique opportunity to connect with others at the Green Label Collective, fostering new relationships and exploring avenues for active involvement in this dynamic movement. For more information and to purchase tickets for the summit, visit https://cnw.fm/gKUab.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

The 2023 Alternative Products Expo, Dallas Chapter – “Everything Counterculture Under One Roof”

ZJ Events is proud to announce the third leg of its four-part Alternative Products Expo – the Dallas Chapter – that will be held at the Kay Bailey Hutchison Convention Center Dallas. The expo, which promises to be the ultimate event for anyone in the counterculture industry, will serve as a melting pot for everything counterculture, with featured products including CBD, mushrooms, nicotine replacement, dietary supplements, and nootropics, among others.

The event will be held from July 13-15, bringing together hundreds of leading brands such as 3Chi, Mellow Fellow, and Cali Kulture. The event will also offer a platform where attendees can connect with top manufacturers, explore the latest trends and innovations, and even take advantage of exclusive show discounts in a fun and exciting atmosphere.

The Dallas Alternative Products expo will allow business owners to stock their businesses with consumer must-haves. Show-exclusive pricing will make this possible, extending to individual consumers or attendees. The event will also be an excellent avenue for getting updated on trends, new products, and hot sellers in the market while also serving as a one-stop shop for counterculture retail professionals.

The Dallas leg of the 2023 Alternative Products Expo stays true to ZJ Events’ mission to facilitate B2B and B2C networking by vertically incorporating the event’s target industry and its complementary services into an unrivaled trade show experience. By gathering the industry’s best under the same roof while providing attendees with a fun, thrilling experience that promotes business networking, the company is promoting counterculture industry expansion while helping to define a budding sector with incredible potential for growth.

To learn more, please visit https://cnw.fm/M9XqB.

For ticketing info, please visit https://cnw.fm/iecII.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lift Toronto 2023 Conference & Expo: Lifting the Rapidly Expanding Cannabis Industry & Community

Cannabis industry leaders, entrepreneurs, policymakers, service providers and consumers are all invited to attend the Lift Toronto 2023 Conference & Expo to be held at Metro Toronto Convention Centre from June 1-3, 2023. The advocacy-oriented, strategy-focused Lift Cannabis Business Conference (“LCBC”) on June 1st kicks off the three-day event and is dedicated to discussing best practices in evolving cannabis industry topics, brushing up on policy matters, and connecting with industry leaders.

The Lift Cannabis Business Conference is an ideal opportunity for those who are serious about thriving in the global cannabis industry; it is the premiere gathering of subject matter experts, cannabis business leaders, regulators and decision-makers. Each speaker and panel offers innovative education about the most pressing issues in our industry.

An Irresistible Experience

Continuing the can’t-miss event for the cannabis industry and community, the expo is open June 2nd & 3rd for Industry and Budtender Days and Consumer Day. Hundreds of companies participating in the expo will gain new business leads, strengthen client relationships, revisit existing customers, and create awareness of their businesses.

In turn, attendees will experience the latest and greatest in cannabis brands, products and innovations across cannabis retail, cultivation and extraction, as well as learn about the operational, technical, and strategic tools you need to grow in this ever-changing, ever-challenging industry. From a 360-degree perspective, Lift Toronto provides a complete opportunity to explore the challenges and opportunities that cannabis businesses face today while getting insights into the products and ideas that will drive the industry forward. Lift events are known for memorable positive experiences, which keep thousands of cannabis industry leaders and trailblazers talking long after an event is over.

To learn more, please visit https://cnw.fm/fH4AW.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Approved to Proceed with Human Study Evaluating Effectiveness of Patented DehydraTECH(TM) Technology in Boosting Oral-Tissue Absorption of Nicotine

  • Lexaria Bioscience recently received Independent Review Board approval for its upcoming human clinical nicotine study, NIC-H22-1, and expects to begin dosing soon
  • The company hopes to evidence that processing purified nicotine with its patented DehydraTECH(TM) drug delivery technology leads to better oral-tissue absorption and reduced negative experiences compared to leading brands currently available on the market, On! and Zyn
  • Last year, Lexaria conducted an animal study evaluating oral nicotine absorption, NIC-A21-1, in which it evidenced that its DehydraTECH technology was ten to twenty times faster in delivering comparable levels of nicotine into the bloodstream than the peak of the concentration-matched controls

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced it had received Independent Review Board (“IRB”) approval for its planned human clinical nicotine study, NIC-H22-1 (https://cnw.fm/gwG7s). According to U.S. Food and Drug Administration (“FDA”) regulations, the receipt of the IRB approval by Lexaria means the company has taken the necessary steps to protect the rights and welfare of humans participating as subjects in its upcoming human study (https://cnw.fm/YiSlP).

The pharmacokinetic (“PK”) randomized, double-blinded, cross-over study will comprise 36 human subjects who are current cigarette smokers. Each subject will visit the laboratory, where they will be dosed three times over a period of weeks. Only one of three nicotine pouch brands – DehydraTECH(TM)-nicotine, On! brand manufactured by Altria, or Zyn brand manufactured by Swedish Match – will be administered during each visit. Subjective and objective evaluations will then follow.

Through predetermined questionnaires, which will be used for each nicotine pouch, aiding in subjective evaluation, Lexaria will seek data related to throat burn, user experience, gastrointestinal experience, and more. Additionally, blood samples taken a total of eight times per visit will help in objective evaluations associated with the quantity of nicotine in the blood at various time points. At the same time, vital signs such as respiratory rate, heart rate, blood pressure, and temperature will also be collected.

“This is a human clinical study to be conducted in the United States. It uses a DehydraTECH-oral nicotine powder that we have developed… The nicotine powder we will be using is one we already tested in animals last year – we had exceptionally strong results,” said CEO Chris Bunka in an interview with Proactive (https://cnw.fm/IcSHT). “We believe, right now, that the Lexaria oral nicotine powder is the most advanced of its kind in the world, and we are going head-to-head with two of the top three leading brands of oral nicotine powders today: those manufactured by Swedish Match as well as by Altria. So, we are really excited for the study to commence.”

Last October, Lexaria announced “outstanding results” from its NIC-A21-1 study evaluating oral nicotine absorption in animals. The company revealed that DehydraTECH needed only 2 to 4 minutes to deliver nicotine levels in blood plasma comparable to levels achieved at 45 minutes with concentration-matched controls. The results also showed that DehydraTECH-nicotine reached statistically significant peak blood plasma levels up to 10x higher overall than controls while still clearing from blood virtually as quickly as the controls. (https://cnw.fm/ZLNMd).

“We are extremely pleased with the performance of our latest DehydraTECH-2.0 nicotine oral formulations in this study,” said Chris Bunka at that time. “Our technology was ten to twenty times faster in delivering comparable levels of nicotine into the bloodstream than the peak of the concentration-matched controls and went on to far exceed their total delivery, which should provide much greater consumer satisfaction.”

Following receipt of the IRB approval, Lexaria expects to begin human dosing soon, with CEO Chris Bunka hinting during the Proactive interview, published November 3, that dosing will “have been completed in the next month or two and results [released] shortly thereafter.” The company hopes to evidence that processing purified nicotine with its patented DehydraTECH drug delivery technology leads to better oral-tissue absorption and reduced negative experiences compared to the brands currently available on the market.

Ultimately, and upon undergoing necessary evaluations, Lexaria hopes to license its technology in the oral pouch product category to offer better nicotine satiety and effectiveness, with the goal of one day rendering cigarette smoking and vaping as obsolete. This would potentially help stop the devastating consequences of cigarette smoking – the practice annually claims more than 480,000 lives in the United States (https://cnw.fm/j3Cgc) and over 8 million lives globally (https://cnw.fm/0m6AB). Smoking is also linked to such maladies as cancer (trachea, lung, and bronchus), bronchitis, and coronary heart disease.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

American Cannabis Partners Committed to Implementing Key Sustainable Operating Practices

  • Forbes reports that “sustainability is increasingly becoming a necessity for corporations due to changing perspectives around the world”
  • Unfortunately, while 90% of executives think sustainability is important, only 60% of companies have a sustainability strategy
  • ACP’s sustainable operating practices appear ideally aligned with today’s expectations

With a focus on sustainability becoming increasingly essential for companies to succeed in today’s market, American Cannabis Partners (“ACP”) has made its sustainable operating practices a top priority. The company is “contending for first place in the U.S. cannabis industry through proven strategies that continue to accelerate ACP in assets, operations, expansions and market share” (https://acpfarms.com).

“Sustainability is increasingly becoming a necessity for corporations due to changing perspectives around the world,” reports Forbes in an article titled “Why Corporate Strategies Should Be Focused on Sustainability.” The article noted that “it is becoming even more critical for companies to address the gap between knowing and doing by embracing sustainable business practices. Sustainability can be defined as providing for the present needs without compromising the needs of the future generations to meet theirs. It has three pillars: economic, environmental and social.”

Forbes reported that, while 90% of executives think sustainability is important, only 60% of companies have a sustainability strategy. “Often, companies that speak of being sustainable are lacking when it comes to implementation,” the article noted. “Economic, social and environmental sustainability is a must in today’s business environment. It has a lot of benefits as well.

The article pointed out several key reasons why organizations should implement sustainability strategies, including adding brand value and a competitive advantage, meeting consumer demand, increasing efficiency, attracting talent and creating new opportunities.

With that in mind, ACP’s sustainable operating practices (https://cnw.fm/d8T9s) appear ideally aligned with today’s expectations. The company is “committed to operating business in a manner that has a positive impact on the environment, employee, and customer experience,” with an organic cultivation model that includes “the implementation of sustainable operating practices that reduce the company’s environmental footprint and increase its social responsibility. A comprehensive approach is taken to maximize impacts on our operations. Use of local purchasing and employment, environment-friendly products, energy and water conservation efforts, and a waste management program have increased our ‘triple bottom line,’ positively impacting people, planet, and profit.”

American Cannabis Partners is focused on three business segments: real estate, acquisition and development of proprietary assets, and ongoing cultivation operations. Led by a seasoned management team with more than three decades of canna-business experience, ACP is guided by its strategy to capture opportunities in real estate and licensing in states that have recently passed cannabis-legalization legislation, thereby equipping the company to capitalize on federal interstate-commerce opportunities.

For more information, visit the company’s website at www.ACPFarms.com.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

AROYA Crop Steering Expertise and Technology Provides Data-Driven Insights, Automation and Competitive Advantage for Successful Harvests

For cannabis operators, crop steering directs how their plants grow as well as their literal shape. Knowing how and when to manipulate light, climate and irrigation – the three foundational components of crop steering – is essential to balancing high yields and high quality.

Why do successful growers – from small craft farmers to the largest multistate operators – use data-driven and automated crop steering solutions? Because even the slightest adjustments to any number of factors can have huge effects on grows.

Data is the lifeblood of a plant growers, providing the intelligence to track how and when plants change from phase to phase and eliminate unknown variables, perfecting each run. The AROYA cultivation solution combines innovative hardware and software to deliver actionable insights from data, improving quality and yield – predictably and at scale.

With data-driven insights into each aspect of harvests, operators are empowered with the knowledge to not only increase yield per square foot, but also establish and employ repeatable best practices that ensure consistent quality. Identifying and adapting to various cues – from light, climate, and irrigation – encourages plants to produce bigger flowers with higher quality as well as finish getting their DNA out into the world before they die in an evolutionary selection process known simply by “stress.”

Generative stress is targeted intentional environmental pressure that encourages a plant’s behavior by focusing on reproductive parts. This not only finishes filling up space for future generations, but also removes unwanted elements like pests. In crop steering, this leads plants to produce almost double the count of bud sites. Also of note is that as every specific cultivar has its own feeding needs, automated crop steering maintains the balance between being too vegetative or too generative in terms of quality and yield.

Despite the increasing use of technology across the industry, many craft and independent farmers are sticking with their tried-and-true manual methods, like physically pouring run-off into milliliter cups, taking notes, and running tests by hand. And to their credit, they’re having success.

Unfortunately, failing to embrace cultivation and production technology will be their demise. In addition to competition from larger operators, many smaller outfits have gone all-in with crop steering, advanced drying and analytics.

Using crop steering tech provides access to easy-to-use, comprehensive tools to collect, analyze, and understand plants on a new level. As a result, they can bring out the most sought-out features of each cultivar.

The ability to consistently deliver the highest-quality products to market is the key to keeping and growing your customer base.

AROYA’s Cannabis Production Platform leverages crop steering solutions and cutting-edge IoT sensor technology to help plants grow better in different environments. Combining patented telemetry systems and software turns data into insights for each phase of growth.

Access to insights and analyses like rising terpenes, fluctuating THC levels, and total cannabinoids brings out the best of each strain. Hitting specific water content, moisture levels, and drying with precision brings the most out of cultivars.

For large operators like STIIIZY, AROYA makes it a lot easier to manage multiple facilities and assign tasks remotely, and to know if at any time a grow is operating outside of certain thresholds. Crop steering enables scalability and growth for STIIIZY, the third best-selling brand in the United States and the number one brand in California – the largest cannabis market in the world.

Analyzing historical records for each stage optimizes growth across all areas, which is how operators like STIIIZY consistently produce runs with higher yields while maintaining production levels and quality. AROYA’s technology enhances cultivation practices – which are repeatable and are implemented in every STIIIZY facility.

Sean Oganesyan, Senior Vice President of Cultivation with STIIIZY, credits the company’s success to data intelligence real-time insights secured from AROYA’s Cannabis Cultivation and Production Platform, which allows him to manage multiple facilities from a single location.

“The concept of sensor density is important, as more sensors deployed across our grows ensures better results and data-driven decisions that eliminate unknown variables. I don’t like variables. I dot all my i’s and cross all my t’s – that’s my military background. I need answers, I need to know exactly what’s going on, I need to be in full control of a situation, and that gave me control. That’s why I’m comfortably sitting here and talking to you today. I’m not going around somewhere in a plane or flying to some different state because somebody messed something up in my irrigation.”

“The communication with the AROYA team is fluid; we both understood what we must gain from each other, and this helps STIIIZY bring good products to the market.”

AROYA’s IoT sensors installed at customer facilities not only observes – but also enables digital interactions between stakeholders involved in every part of the cannabis cultivation process – from selecting nutrients to use during vegetative periods down to dietary instructions once flowerheads start forming on branches.

Cultivators rely on giving plants an ideal amount of light each day; the AROYA platform provides access to this data, delivering insights on exactly what percentiles lights need to stay at with specific plants and the amount of coverage within each room, allowing growers to adjust lighting quicker using data-driven decisions.

With BACnet access to AROYA with STIIIZY’s fully controlled system, Oganesyan can communicate with his controls with AROYAs sensors to make decisions for plants based on real-time data and recipes assigned to specific cultivars, adjusting things like irrigation based on EC readings in a plant’s substrate.

“AROYA gives me full control of my irrigation cycles,” said Oganesyan. “I have the full analytics team behind it continuously monitoring multiple locations. All my grows are literally run through my headquarters in downtown Los Angeles.”

Operators must be able to account for everything that’s going on inside their facilities, and even if you have the tightest controls, there’s still going to be variables that are just inherent to the cannabis industry, such as plant variation.

Oganesyan touted AROYA’s differentiators and superior technology among the biggest selling points for selecting AROYA over other systems.

“If you got a company that makes sensors and you got all the other companies buying those sensors, white labeling those sensors and want to put their name on it, I just go straight to the source.”

ABOUT AROYA

AROYA is a cannabis production platform that combines industry-leading hardware and software to help cultivators increase yield, scale operations, and achieve consistent quality. Based in Pullman, Washington, and a division of METER Group, Inc., AROYA optimizes and demystifies the entire cannabis production process from seed to package.

For additional information, please visit AROYA.io.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Third-Party Content

The CNW website may contain Third-Party Content articles and other content submitted by third parties, including articles submitted through the CNW Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of CNW or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and CNW does not endorse, guarantee or make representations concerning the accuracy and completeness of any third-party content. You acknowledge that by CNW providing you with this internet portal that makes accessible to you the ability to view third party content through the CNW site, CNW does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. CNW expressly disclaims liability relating to such third-party content. CNW and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, CNW reserves the right to remove third-party content at any time in its sole discretion. By viewing this third-party content, you acknowledge that you have viewed, read fully, accepted and agreed to all terms of the Disclaimer at https://www.cannabisnewswire.com/disclaimer.

CannabisNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) Vessel Enters Distribution Agreement with JustCBD Partner

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has inked a distribution deal with Florida-based Speedy Distribution. Speedy is a core partner of JustCBD, which was just acquired by Flora Growth in a transaction announced earlier this week. The announcement noted that its consumer technology brand, Vessel, will launch in Speedy’s cash-and-carry distribution center and will include a select offering from FLGC’s product portfolio; the products will expand into traditional smokeshop channels. JustCBD has more than 300 products and some 300,000 customers, with a network of more than 14,000 stores across the United States and internationally. This agreement marks Vessel’s initial entry into traditional smokeshop channels; the company plans to explore additional opportunities, including innovating and designing new products and accessories specifically for this newly formed channel partnership. The company has scheduled a webinar for today at 1 p.m. ET to discuss the distribution agreement and other aspects of the acquisition. Flora CEO Luis Merchan, Flora chief strategy officer James Choe and JustCBD CEO Hussein Rakine will facilitate the event. “We are excited to bring the Vessel product offering to one of our core distribution partners in Speedy,” said JustCBD CEO Hussein Rakine in the press release. “The Vessel team designs excellent customer experiences, and whether through e-commerce or traditional wholesale, the products are always well received by customers. We see this agreement as the first of many where we leverage JustCBD’s existing distribution network and Flora’s diverse product portfolio to amplify growth for our combined company.”

To view the webinar, visit https://cnw.fm/hFaps

To view the full press release, visit https://cnw.fm/B7hR5

About Flora Growth Corp.

Flora is building a design-led collective of plant-based wellness and lifestyle brands that delivers the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Is World Leader Through DehydraTECH(TM) – Its Pioneering Drug Delivery Technology

Lexaria Bioscience Corp. (NASDAQ: LEXX) commented on an independent study headed by lead research scientist Dr. Richard van Breeman, which discovered that cannabinoids can block cellular entry of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its emerging variants. The study showed that smoking and vaping are likely ineffective measures, whereas oral delivery methods are. “As a company, Lexaria is already actively exploring and researching DehydraTECH(TM)-enabled cannabinoid formulations across various potential therapeutic applications, including oral formulations that are being prepared for registered clinical trials as a possible new pharmaceutical product,” reads a recent article. “In response to the study, Chris Bunka, CEO of Lexaria Bioscience, said, ‘Lexaria has led the conversation for years related to oral delivery of cannabinoids and is a world leader through its pioneering drug delivery technology, DehydraTECH, in more effective delivery of cannabinoids to the human bloodstream through oral means.’… Lexaria previously announced in June 2021 that the DehydraTECH-enabled remdesivir and ebastine effectively inhibited the SARS-CoV-2 virus.”

To view the full article, visit https://cnw.fm/2nOf1

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce time of onset from one to two hours to minutes, and mask unwanted tastes. The technology is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 23 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.